5-[7-(cyclopropylamino)-3-[(Z)-(5-methylidene-2-oxoimidazolidin-4-ylidene)methyl]pyrazolo[1,5-a]pyrimidin-5-yl]-N-[(1-ethylpyrrolidin-2-yl)methyl]thiophene-2-carboxamide;5-[7-(cyclopropylamino)-3-[(Z)-(5-methylidene-2-oxoimidazolidin-4-ylidene)methyl]pyrazolo[1,5-a]pyrimidin-5-yl]-N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]thiophene-2-carboxamide;5-[7-(cyclopropylamino)-3-[(Z)-(5-methylidene-2-oxoimidazolidin-4-ylidene)methyl]pyrazolo[1,5-a]pyrimidin-5-yl]-N-[(2R)-1-hydroxy-3-methylbutan-2-yl]thiophene-2-carboxamide;(4Z)-4-[[7-(cyclopropylamino)-5-[5-(4-propan-2-ylpiperazine-1-carbonyl)thiophen-2-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylideneimidazolidin-2-one
C102H117N31O9S4 — CID 161426094
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[7-(cyclopropylamino)-3-[(Z)-(5-methylidene-2-oxoimidazolidin-4-ylidene)methyl]pyrazolo[1,5-a]pyrimidin-5-yl]-N-[(1-ethylpyrrolidin-2-yl)methyl]thiophene-2-carboxamide;5-[7-(cyclopropylamino)-3-[(Z)-(5-methylidene-2-oxoimidazolidin-4-ylidene)methyl]pyrazolo[1,5-a]pyrimidin-5-yl]-N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]thiophene-2-carboxamide;5-[7-(cyclopropylamino)-3-[(Z)-(5-methylidene-2-oxoimidazolidin-4-ylidene)methyl]pyrazolo[1,5-a]pyrimidin-5-yl]-N-[(2R)-1-hydroxy-3-methylbutan-2-yl]thiophene-2-carboxamide;(4Z)-4-[[7-(cyclopropylamino)-5-[5-(4-propan-2-ylpiperazine-1-carbonyl)thiophen-2-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylideneimidazolidin-2-one
5-[7-(cyclopropylamino)-3-[(Z)-(5-methylidene-2-oxoimidazolidin-4-ylidene)methyl]pyrazolo[1,5-a]pyrimidin-5-yl]-N-[(1-ethylpyrrolidin-2-yl)methyl]thiophene-2-carboxamide;5-[7-(cyclopropylamino)-3-[(Z)-(5-methylidene-2-oxoimidazolidin-4-ylidene)methyl]pyrazolo[1,5-a]pyrimidin-5-yl]-N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]thiophene-2-carboxamide;5-[7-(cyclopropylamino)-3-[(Z)-(5-methylidene-2-oxoimidazolidin-4-ylidene)methyl]pyrazolo[1,5-a]pyrimidin-5-yl]-N-[(2R)-1-hydroxy-3-methylbutan-2-yl]thiophene-2-carboxamide;(4Z)-4-[[7-(cyclopropylamino)-5-[5-(4-propan-2-ylpiperazine-1-carbonyl)thiophen-2-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylideneimidazolidin-2-one (PubChem CID 161426094) has the molecular formula C102H117N31O9S4 and a molecular weight of 2049.53 g/mol. Its IUPAC name is 5-[7-(cyclopropylamino)-3-[(Z)-(5-methylidene-2-oxoimidazolidin-4-ylidene)methyl]pyrazolo[1,5-a]pyrimidin-5-yl]-N-[(1-ethylpyrrolidin-2-yl)methyl]thiophene-2-carboxamide;5-[7-(cyclopropylamino)-3-[(Z)-(5-methylidene-2-oxoimidazolidin-4-ylidene)methyl]pyrazolo[1,5-a]pyrimidin-5-yl]-N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]thiophene-2-carboxamide;5-[7-(cyclopropylamino)-3-[(Z)-(5-methylidene-2-oxoimidazolidin-4-ylidene)methyl]pyrazolo[1,5-a]pyrimidin-5-yl]-N-[(2R)-1-hydroxy-3-methylbutan-2-yl]thiophene-2-carboxamide;(4Z)-4-[[7-(cyclopropylamino)-5-[5-(4-propan-2-ylpiperazine-1-carbonyl)thiophen-2-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylideneimidazolidin-2-one.
Molecular Properties
| Compound Name | 5-[7-(cyclopropylamino)-3-[(Z)-(5-methylidene-2-oxoimidazolidin-4-ylidene)methyl]pyrazolo[1,5-a]pyrimidin-5-yl]-N-[(1-ethylpyrrolidin-2-yl)methyl]thiophene-2-carboxamide;5-[7-(cyclopropylamino)-3-[(Z)-(5-methylidene-2-oxoimidazolidin-4-ylidene)methyl]pyrazolo[1,5-a]pyrimidin-5-yl]-N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]thiophene-2-carboxamide;5-[7-(cyclopropylamino)-3-[(Z)-(5-methylidene-2-oxoimidazolidin-4-ylidene)methyl]pyrazolo[1,5-a]pyrimidin-5-yl]-N-[(2R)-1-hydroxy-3-methylbutan-2-yl]thiophene-2-carboxamide;(4Z)-4-[[7-(cyclopropylamino)-5-[5-(4-propan-2-ylpiperazine-1-carbonyl)thiophen-2-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylideneimidazolidin-2-one |
|---|---|
| PubChem CID | 161426094 |
| Molecular Formula | C102H117N31O9S4 |
| Molecular Weight | 2049.53 g/mol |
| Exact Mass | 2047.85 |
| IUPAC Name | 5-[7-(cyclopropylamino)-3-[(Z)-(5-methylidene-2-oxoimidazolidin-4-ylidene)methyl]pyrazolo[1,5-a]pyrimidin-5-yl]-N-[(1-ethylpyrrolidin-2-yl)methyl]thiophene-2-carboxamide;5-[7-(cyclopropylamino)-3-[(Z)-(5-methylidene-2-oxoimidazolidin-4-ylidene)methyl]pyrazolo[1,5-a]pyrimidin-5-yl]-N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]thiophene-2-carboxamide;5-[7-(cyclopropylamino)-3-[(Z)-(5-methylidene-2-oxoimidazolidin-4-ylidene)methyl]pyrazolo[1,5-a]pyrimidin-5-yl]-N-[(2R)-1-hydroxy-3-methylbutan-2-yl]thiophene-2-carboxamide;(4Z)-4-[[7-(cyclopropylamino)-5-[5-(4-propan-2-ylpiperazine-1-carbonyl)thiophen-2-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methylidene]-5-methylideneimidazolidin-2-one |
| SMILES | C=c1[nH]c(=O)[nH]/c1=C\c1cnn2c(NC3CC3)cc(-c3ccc(C(=O)N4CCN(C(C)C)CC4)s3)nc12.C=c1[nH]c(=O)[nH]/c1=C\c1cnn2c(NC3CC3)cc(-c3ccc(C(=O)NCC4CCCN4CC)s3)nc12.C=c1[nH]c(=O)[nH]/c1=C\c1cnn2c(NC3CC3)cc(-c3ccc(C(=O)NC[C@@H]4CCCN4CC)s3)nc12.C=c1[nH]c(=O)[nH]/c1=C\c1cnn2c(NC3CC3)cc(-c3ccc(C(=O)N[C@@H](CO)C(C)C)s3)nc12 |
| InChI | InChI=1S/3C26H30N8O2S.C24H27N7O3S/c1-15(2)32-8-10-33(11-9-32)25(35)22-7-6-21(37-22)20-13-23(29-18-4-5-18)34-24(30-20)17(14-27-34)12-19-16(3)28-26(36)31-19;2*1-3-33-10-4-5-18(33)14-27-25(35)22-9-8-21(37-22)20-12-23(30-17-6-7-17)34-24(31-20)16(13-28-34)11-19-15(2)29-26(36)32-19;1-12(2)18(11-32)29-23(33)20-7-6-19(35-20)17-9-21(27-15-4-5-15)31-22(28-17)14(10-25-31)8-16-13(3)26-24(34)30-16/h6-7,12-15,18,29H,3-5,8-11H2,1-2H3,(H2,28,31,36);2*8-9,11-13,17-18,30H,2-7,10,14H2,1H3,(H,27,35)(H2,29,32,36);6-10,12,15,18,27,32H,3-5,11H2,1-2H3,(H,29,33)(H2,26,30,34)/b19-12-;2*19-11-;16-8-/t;18-;;18-/m.0.0/s1 |
| InChIKey | VXJLDXCGHHYHNT-XBWUDMTFSA-N |
| XLogP | 5.49 |
| TPSA | 501.04 Ų |
| H-Bond Donors | 16 |
| H-Bond Acceptors | 32 |
| Rotatable Bonds | 30 |
| Heavy Atoms | 146 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2049.53 |
| LogP ≤ 5 | 5.49 |
| H-Bond Donors ≤ 5 | 16 |
| H-Bond Acceptors ≤ 10 | 32 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 161426094 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.